Leyden Laboratories B.V ▲ Sign in to save

• ▲ Galit Alter

  Harvard University · Ragon Institute of MGH, MIT and Harvard Medicine
  54.5k

  citations

  118

  h-index

  3

  Aachen papers
• ▲ Jaap Goudsmit

  Harvard University · Leyden Laboratories BV (Netherlands) Immunology and Microbiology
  34.7k

  citations

  99

  h-index

  8

  Aachen papers
• ▲ Wouter Koudstaal

  Leyden Laboratories BV (Netherlands) Medicine
  5.51k

  citations

  25

  h-index

  3

  Aachen papers
• ▲ Jaco M. Klap

  Leyden Laboratories BV (Netherlands) Medicine
  1.75k

  citations

  18

  h-index

  8

  Aachen papers
• ▲ Clarissa M. Koch

  Leyden Laboratories BV (Netherlands) Medicine
  1.04k

  citations

  15

  h-index

  8

  Aachen papers
• ▲ Anna L. Beukenhorst

  Harvard University · Leyden Laboratories BV (Netherlands) Health Professions
  633

  citations

  14

  h-index

  9

  Aachen papers
• ▲ Jacopo Frallicciardi

  Leyden Laboratories BV (Netherlands) Biochemistry, Genetics and Molecular Biology
  572

  citations

  9

  h-index

  7

  Aachen papers

7 results

• The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

  2022 Frontiers in Virology article Medicine Influenza Virus Research Studies Open access cited by 1 patent

  18

  citations
• Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community

  2022 Infectious Diseases and Therapy article Medicine SARS-CoV-2 and COVID-19 Research Open access

  12

  citations
• Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

  2023 Frontiers in Virology erratum Medicine Influenza Virus Research Studies Open access

  1

  citations

3 results